| Literature DB >> 29629436 |
Haidong Dong1,2, Yiyi Yan3,4, Roxana S Dronca3, Svetomir N Markovic1,4.
Abstract
Following antigen stimulation, the net outcomes of a T cell response are shaped by integrated signals from both positive co-stimulatory and negative regulatory molecules. Recently, the blockade of negative regulatory molecules (i.e. immune checkpoint signals) demonstrates promising therapeutic effects in treatment of human cancers, but only in a fraction of cancer patients. Since this therapy is aimed to enhance T cell responses to cancers, here we devised a conceptual model by integrating both positive and negative signals in addition to antigen stimulation that can evaluate strategies to enhance T cell responses. A digital range of adjustment of each signal is formulated in our model for prediction of a final T cell response. Our model provides a rational combination strategy for maximizing the therapeutic effects of cancer immunotherapy.Entities:
Year: 2017 PMID: 29629436 PMCID: PMC5884168 DOI: 10.15226/2372-0948/5/1/00155
Source DB: PubMed Journal: SOJ Immunol